DOD issues notice of a TRICARE OTC project
The Department of Defense has issued a notice advising interested parties of a demonstration project in which the department will evaluate allowing selected OTCs to be included on the TRICARE uniform formulary.
The Department of Defense has issued a notice advising interested parties of a demonstration project in which the department will evaluate allowing selected OTCs to be included on the TRICARE uniform formulary. The demonstration project will be available for beneficiaries within the U.S., Puerto Rico, the Virgin Islands, and Guam. The notice appeared in the June 15 Federal Register. For more information, call (703) 681-2890.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Q&A: Retail, Independent Pharmacies Continue to Call for Improved Reimbursement Practices
June 30th 2025Rick Gates, chief pharmacy officer at Walgreens and chairman of the National Association of Chain Drug Stores, discussed the current status of retail pharmacies and the way they are reimbursed.
